Skip to content
Agentic OS
Menu

Intelligence / Healthtech / New Clinical Trials

ClinicalLIVEUpdated 18 Nov 2026

New Clinical Trials

Clinical trials companies registered in the last 30 days, worldwide, with the sponsor, phase and countries.

Sources: ClinicalTrials.gov · Rebuilt weekly · Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase.

Trials
777
in the 30 days to 2026-11-18
Added in 30 days
777
to 18 Nov 2026
Top country
United States
192 · 25% of the list
Phase covered
8
distinct values
Snapshot · 18 Nov 2026
Explore all 777

Signals

What the register says this week, and why it matters if you sell into it.

  1. United States leads with 192 of 777, then China (171).
  2. 777 added in the 30 days to 18 Nov 2026.
  3. 174 of the listed studies are device, diagnostic or digital-health studies (no drug phase).
  4. A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.

Export the full new clinical trials

777 rows as a .csv. Free. Every field, with its source link.

Country
Phase
Study type
777 / 777 trials
PostedSponsorStudyPhaseStatus
2 Nov 2026Novartis PharmaceuticalsIsraelA Study of TRB191 in Patients With Extensive-stage Small Cell Lung CancerPhase 1Recruiting2 Nov 2026Nutrition 21, Inc.United StatesAn Open Label Pilot Study Assessing the Impact of Chromium Picolinate Supplementation on Appetite and Cravings in Overweight IndividualsRecruiting2 Nov 2026Ouraring Inc.United StatesOura Ring OA15 ValidationRecruiting2 Nov 2026Peijia Medical Technology (Suzhou) Co., Ltd.ChinaTarget Value Study to Evaluate the Safety and Efficacy of the Taurus NXT® Transcatheter Aortic Valve System for the Treatment of Severe Calcific Aortic StenosisNot applicableActive Not Recruiting2 Nov 2026PfizerReal-World Treatment Patterns and Effectiveness of Anti-EGFR- and Anti-VEGF-based Therapies in Left-sided RAS Wild-Type Metastatic Colorectal CancerNot Yet Recruiting2 Nov 2026Replior ABFranceObservational Analytical Validation Study of the Replior ScratchSenseRecruiting2 Nov 2026Shanghai Huaota Biopharmaceutical Co., Ltd.ChinaA Phase 2 Study of HB0056 in Patients With Idiopathic Pulmonary FibrosisPhase 2Not Yet Recruiting2 Nov 2026SolsiusFranceContinuous Monitoring of Plantar Temperature Variations Using Connected Insoles and a Mobile Application for Diabetic Foot.Not applicableRecruiting2 Nov 2026SunGlow Innovations LLCIntratumoral Chlorine Dioxide Injection in Advanced Solid TumorsPhase 1Not Yet Recruiting2 Nov 2026Swedish Orphan BiovitrumUnited StatesLong Term Safety Study in Patients With HLH/MAS in Still's Disease Exposed to Gamifant.Not Yet Recruiting2 Nov 2026The HumanixIrelandShower Gel and Participant-Reported Post-Exercise Soreness in Regular ExercisersNot applicableRecruiting2 Nov 2026Vascutek Ltd.Clinical Health Outcomes Evaluation of Terumo Aortic Hybrid DevicesNot Yet Recruiting30 Oct 2026Abbott Point of CareUnited StatesEvaluate Precision of the Test for Lactate in Capillary Whole Blood Specimens Using the i-STAT CG4+ Cartridge With the i-STAT 1 AnalyzerNot Yet Recruiting30 Oct 2026Ahn-Gook Pharmaceuticals Co.,LtdA Study to Evaluate the Effectiveness and Safety of S-amlodipine-based Monotherapy and Combination TherapyNot Yet Recruiting30 Oct 2026ATEMs Co., Ltd.South KoreaClinical Trial of Type II Collagen vs. Sodium Hyaluronate Intra-articular Injection in Knee OsteoarthritisNot applicableCompleted30 Oct 2026Boehringer IngelheimUnited States, Italy, MalaysiaThe AIRWARD Study: A Study to Test Whether Verducatib Helps People With Chronic Obstructive Pulmonary DiseasePhase 3Not Yet Recruiting30 Oct 2026Boehringer IngelheimGermanyA Study to Test How Well Different Doses of BI 3821001 Are Tolerated by Healthy PeoplePhase 1Recruiting30 Oct 2026Bosch Quantum Sensing GmbHGermanyMagnetic Field Maps With NV Application Kit MCGRecruiting30 Oct 2026Clinical Research Consultants, Inc.PAUL® Glaucoma Implant Safety and Effectiveness StudyNot applicableNot Yet Recruiting30 Oct 2026Hoffmann-La RocheA Study to Evaluate the Safety and Effectiveness of Different Doses of RO7836748 Alone or in Combination With Other Cancer Therapies in People With Solid Tumors With a Rat Sarcoma Viral Oncogene Homolog Glycine 12 Valine (RAS G12V) MutationPhase 1Not Yet Recruiting30 Oct 2026Immunis, Inc.Safety and Tolerability of Single and Repeated Dose of IMM02-KORA in PD-associated DyskinesiaPhase 1Not Yet Recruiting30 Oct 2026IpsenA Study of Fatigue, Itching and Daily Activities in People With Primary Biliary Cholangitis Starting ElafibranorNot Yet Recruiting30 Oct 2026Janssen Research & Development, LLCUnited States, IsraelA Study of JNJ-101556143 With Best Supportive Care in Participants With Metastatic Prostate CancerPhase 3Recruiting30 Oct 2026Juro Sciences Inc.JapanA Proof-Of-Concept (POC) Study of SFG-02 Transdermal Formulation in Participants With Underactive Bladder (UAB)Phase 2Recruiting30 Oct 2026MED-EL Elektromedizinische Geräte GmbHGermanyPost-Market Registry Study for Vibrant Hearing SolutionsEnrolling By Invitation30 Oct 2026Neurelis, Inc.Study to Establish Safety, Tolerability and Pharmacokinetics of NRL-1049 in Healthy Adult Participants Following Multiple-Dose AdministrationPhase 1Not Yet Recruiting30 Oct 2026Pelage Pharmaceuticals, Inc.United StatesPhase 2 Efficacy and Safety of PP405 in Adult Females With Androgenetic AlopeciaPhase 2Recruiting30 Oct 2026PfizerUnited StatesEfficacy of Rimegepant 75 mg for the Acute Treatment of Migraine: a Bayesian Individual Participant Data Meta-analysis Standardized to Defined Target PopulationsActive Not Recruiting30 Oct 2026Sachi Bioworks Inc.United StatesA Study of Single Ascending Doses of NI112 in Adults With Amyotrophic Lateral Sclerosis (ALS)Phase 1Not Yet Recruiting30 Oct 2026SanofiItalyA Retrospective Cohort Study Evaluating Major Adverse Cardiovascular Events and Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease Without Prior Ischemic Events (OPTIMUS RISK - Italy)Completed30 Oct 2026Shanghai Hengrui Pharmaceutical Co., Ltd.ChinaA Study to Assess the Effect of Itraconazole on the Pharmacokinetics of HRS-4642 Following Intravenous Infusion in Healthy ParticipantsPhase 1Not Yet Recruiting30 Oct 2026Shanghai Qilu Pharmaceutical Research and Development Center LTDA Phase 1 Study of QLS2416 Injection in Participants With Autoimmune DiseasesPhase 1Not Yet Recruiting30 Oct 2026STORM Therapeutics LTDExpanded Access Program to Provide STC-15 to Patients With Selected Advanced CancerAvailable30 Oct 2026Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. LtdChinaA Mass Balance Study on [14C]Levornidazole Disodium Phosphate for Injection in Healthy Chinese Adult Male SubjectsPhase 1Completed30 Oct 2026Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. LtdChinaPharmacokinetics and Safety of Levornidazole Disodium Phosphate for Injection in Chinese Patients With Hepatic ImpairmentPhase 1Completed30 Oct 2026Zoll Medical CorporationRegistry of Central Sleep Apnea Patients Undergoing remedē System ImplantNot Yet Recruiting29 Oct 2026AbbViePlatform Study of Targeted Therapies for Adults With Moderately to Severely Active Rheumatoid ArthritisPhase 2Not Yet Recruiting29 Oct 2026Aperta Biosciences, LLCGuatemalaA Phase 2 Study to Compare Efficacy and Safety of a Novel Topical Therapy (APT-001, Spinosad 1.8%) in Patients With BlepharitisPhase 2Not Yet Recruiting29 Oct 2026AstraZenecaChinaClarify HPP: Disease Burden of HPP Patients in ChinaRecruiting29 Oct 2026AxomoveFranceEvaluation of the Axomove Therapy Medical Device to Facilitate Adapted Physical Activity for Patients With ObesityNot applicableNot Yet Recruiting29 Oct 2026Aymes International LimitedUnited KingdomTolerance and Acceptability of an Oral Nutrition SupplementNot applicableNot Yet Recruiting29 Oct 2026Beeline Medicines CorporationAustraliaA Phase 1, First-in-Human Trial of BLN-481in Healthy Adult ParticipantsPhase 1Recruiting29 Oct 2026BeOne MedicinesA Study of BON-C1393 in Adults With Advanced Solid TumorsPhase 1Not Yet Recruiting29 Oct 2026bioLytical LaboratoriesStudy to Evaluate the Performance of the INSTI® HCV Antibody Test for Point-of-Care Use in Individuals at Risk for HCV Infection or Presenting With Signs or Symptoms of HCV InfectionNot applicableNot Yet Recruiting29 Oct 2026bioLytical LaboratoriesClinical Study to Evaluate the Performance of the INSTI® HCV Antibody Test for CLIA-Waived UseNot applicableNot Yet Recruiting29 Oct 2026BTL Industries Ltd.CzechiaComparison of High-Intensity and Conventional Physical Therapy in Musculoskeletal DisordersNot applicableNot Yet Recruiting29 Oct 2026CareDxMolecular Evidence of Rejection Intervention TrialNot applicableNot Yet Recruiting29 Oct 2026Cibus Therapeutics, Inc.AustraliaA Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Food Effect of CBT-248 in Healthy Adult ParticipantsPhase 1Recruiting29 Oct 2026Cytogel Pharma, LLCUnited StatesA Study of CYT-1010 in Healthy Volunteers and Participants With Acute Pain After Third Molar ExtractionPhase 1, Phase 2Recruiting29 Oct 2026Elixiron Immunotherapeutics Inc.TaiwanA Phase 1, Open-Label, Two-Stage, Food Effect Study to Assess the Safety, Tolerability, and Pharmacokinetics of EI-1071 Under Fasted or Fed Conditions in Healthy VolunteersPhase 1Not Yet Recruiting

// How AOS uses this

Every row here is a potential account. AOS finds the ones that need what you sell, maps the decision makers and prepares the outreach for your approval.